rs121907936
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PP3PM2_SupportingPS3_ModeratePM3_SupportingPP4_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000152.5:c.953T>A variant in GAA is a missense variant predicted to cause substitution of methionine by lysine at amino acid 318 (p.Met318Lys). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was found in compound heterozygosity (phase unknown) with a unique pathogenic variant in GAA in one patient with Pompe disease (PMID:21484825). Additional cases (PMID:18425781) have been reported but were not included because a second variant and/or zygosity was not specified (PP4_Moderate, PM3_Supporting). Expression of the variant in COS cells resulted in 3.2% wild type GAA activity and evidence of abnormal GAA synthesis and processing, leading the variant to be described as Class B (“potentially less severe”), indicating that this variant may impact protein function (PMID 22644586)(PS3_Moderate). The computational predictor REVEL gives a score of 0.926 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3). There is a ClinVar entry for this variant (Variation ID: 558700; 1 star review status) with 1 submitter classifying the variant as likely pathogenic and 1 submitter classifying the variant as a VUS. In summary, this variant meets the criteria to be classified as likely pathogenic for Pompe disease based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Storage Disorders Variant Curation Expert panel (Specifications Version 2.0): PP4_Moderate, PS3_Moderate, PP3, PM2_Supporting, PM3_Supporting. (Classification approved by the ClinGen LSD VCEP - Oct. 19, 2021). LINK:https://erepo.genome.network/evrepo/ui/classification/CA401364275/MONDO:0009290/010
Frequency
Consequence
NM_000152.5 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease IIInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- glycogen storage disease due to acid maltase deficiency, infantile onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- glycogen storage disease due to acid maltase deficiency, late-onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAA | MANE Select | c.953T>A | p.Met318Lys | missense splice_region | Exon 5 of 20 | NP_000143.2 | P10253 | ||
| GAA | c.953T>A | p.Met318Lys | missense splice_region | Exon 6 of 21 | NP_001073271.1 | P10253 | |||
| GAA | c.953T>A | p.Met318Lys | missense splice_region | Exon 5 of 20 | NP_001073272.1 | P10253 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAA | TSL:1 MANE Select | c.953T>A | p.Met318Lys | missense splice_region | Exon 5 of 20 | ENSP00000305692.3 | P10253 | ||
| GAA | TSL:1 | c.953T>A | p.Met318Lys | missense splice_region | Exon 6 of 21 | ENSP00000374665.3 | P10253 | ||
| GAA | c.953T>A | p.Met318Lys | missense splice_region | Exon 5 of 20 | ENSP00000603465.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 52
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at